CKD Bio Corp.

KOSE:A063160 Stok Raporu

Piyasa değeri: ₩132.8b

CKD Bio Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Hui Kang

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliğin/a
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresiVeri yok

Son yönetim güncellemeleri

Recent updates

What You Need To Know About CKD Bio Corp.'s (KRX:063160) Investor Composition

Feb 28
What You Need To Know About CKD Bio Corp.'s (KRX:063160) Investor Composition

Is CKD Bio's (KRX:063160) 203% Share Price Increase Well Justified?

Feb 01
Is CKD Bio's (KRX:063160) 203% Share Price Increase Well Justified?

CKD Bio (KRX:063160) Takes On Some Risk With Its Use Of Debt

Jan 11
CKD Bio (KRX:063160) Takes On Some Risk With Its Use Of Debt

What CKD Bio Corp.'s (KRX:063160) ROE Can Tell Us

Dec 21
What CKD Bio Corp.'s (KRX:063160) ROE Can Tell Us

Here's Why We Don't Think CKD Bio's (KRX:063160) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30
Here's Why We Don't Think CKD Bio's (KRX:063160) Statutory Earnings Reflect Its Underlying Earnings Potential

CEO

Hui Kang

no data

Görev süresi

Mr. Hui Yil Kang serves as a Co-Chief Executive Officer, Vice President, and Director of Ckd Bio Corporation.